Cryoport, Inc. (NASDAQ:CYRX) Insider Mark W. Sawicki Sells 1,367 Shares of Stock

Cryoport, Inc. (NASDAQ:CYRXGet Free Report) insider Mark W. Sawicki sold 1,367 shares of the stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $17.54, for a total transaction of $23,977.18. Following the transaction, the insider now directly owns 77,444 shares of the company’s stock, valued at approximately $1,358,367.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Cryoport Stock Down 0.4 %

Shares of CYRX opened at $17.35 on Wednesday. The stock has a market capitalization of $849.80 million, a PE ratio of -7.89 and a beta of 1.61. Cryoport, Inc. has a 1 year low of $9.00 and a 1 year high of $24.30. The company has a debt-to-equity ratio of 0.82, a quick ratio of 11.16 and a current ratio of 11.73. The company’s 50-day simple moving average is $15.87 and its 200-day simple moving average is $14.35.

Analysts Set New Price Targets

Several brokerages have weighed in on CYRX. Needham & Company LLC lowered their target price on shares of Cryoport from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, March 13th. UBS Group increased their target price on shares of Cryoport from $14.50 to $17.00 and gave the stock a “neutral” rating in a research note on Friday, March 15th. Finally, Stephens reaffirmed an “equal weight” rating and set a $17.00 target price on shares of Cryoport in a research note on Wednesday, March 13th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $18.29.

Read Our Latest Stock Analysis on CYRX

Institutional Trading of Cryoport

Several hedge funds have recently made changes to their positions in CYRX. Cadian Capital Management LP lifted its position in shares of Cryoport by 298.2% during the third quarter. Cadian Capital Management LP now owns 2,656,739 shares of the company’s stock worth $36,424,000 after purchasing an additional 1,989,598 shares in the last quarter. Morgan Stanley lifted its position in shares of Cryoport by 431.2% during the third quarter. Morgan Stanley now owns 1,525,079 shares of the company’s stock worth $20,909,000 after purchasing an additional 1,237,953 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in Cryoport by 487.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,393,156 shares of the company’s stock valued at $21,580,000 after acquiring an additional 1,156,106 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Cryoport by 46.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,992,895 shares of the company’s stock valued at $30,870,000 after acquiring an additional 636,395 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Cryoport by 17.7% in the first quarter. Invesco Ltd. now owns 3,228,313 shares of the company’s stock valued at $112,700,000 after acquiring an additional 485,972 shares in the last quarter. Institutional investors and hedge funds own 92.90% of the company’s stock.

About Cryoport

(Get Free Report)

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

Read More

Insider Buying and Selling by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.